Bacteremia in solid organ transplant recipients as compared to immunocompetent patients: Acute phase cytokines and outcomes in a prospective, matched cohort study.
dc.contributor.author | Eichenberger, Emily M | |
dc.contributor.author | Ruffin, Felicia | |
dc.contributor.author | Dagher, Michael | |
dc.contributor.author | Lerebours, Reginald | |
dc.contributor.author | Jung, Sin-Ho | |
dc.contributor.author | Sharma-Kuinkel, Batu | |
dc.contributor.author | Macintyre, Andrew N | |
dc.contributor.author | Thaden, Joshua T | |
dc.contributor.author | Sinclair, Matthew | |
dc.contributor.author | Hale, Lauren | |
dc.contributor.author | Kohler, Celia | |
dc.contributor.author | Palmer, Scott M | |
dc.contributor.author | Alexander, Barbara D | |
dc.contributor.author | Fowler, Vance G | |
dc.contributor.author | Maskarinec, Stacey A | |
dc.date.accessioned | 2022-02-01T20:02:06Z | |
dc.date.available | 2022-02-01T20:02:06Z | |
dc.date.issued | 2021-06 | |
dc.date.updated | 2022-02-01T20:02:05Z | |
dc.description.abstract | We undertook a prospective, matched cohort study of patients with Staphylococcus aureus bacteremia (SAB) and gram-negative bacteremia (GNB) to compare the characteristics, outcomes, and chemokine and cytokine response in transplant recipients to immunocompetent, nontransplant recipients. Fifty-five transplant recipients (GNB n = 29; SAB n = 26) and 225 nontransplant recipients (GNB n = 114; SAB n = 111) were included for clinical analysis. Transplant GNB had a significantly lower incidence of septic shock than nontransplant GNB (10.3% vs 30.7%, p = .03). Thirty-day mortality did not differ significantly between transplant and nontransplant recipients with GNB (10.3% vs 15.8%, p = .57) or SAB (0.0% vs 11.7%, p = .13). Next, transplant patients were matched 1:1 with nontransplant patients for the chemokine and cytokine analysis. Five cytokines and chemokines were significantly lower in transplant GNB vs nontransplant GNB: IL-2 (median [IQR]: 7.1 pg/ml [7.1, 7.1] vs 32.6 pg/ml [7.1, 88.0]; p = .001), MIP-1β (30.7 pg/ml [30.7, 30.7] vs 243.3 pg/ml [30.7, 344.4]; p = .001), IL-8 (32.0 pg/ml [5.6, 53.1] vs 59.1 pg/ml [39.2, 119.4]; p = .003), IL-15 (12.0 pg/ml [12.0, 12.0] vs 12.0 pg/ml [12.0, 126.7]; p = .03), and IFN-α (5.1 pg/mL [5.1, 5.1] vs 5.1 pg/ml [5.1, 26.3]; p = .04). Regulated upon Activation, Normal T Cell Expressed and Secreted (RANTES) was higher in transplant SAB vs nontransplant SAB (mean [SD]: 750.2 pg/ml [194.6] vs 656.5 pg/ml [147.6]; p = .046). | |
dc.identifier.issn | 1600-6135 | |
dc.identifier.issn | 1600-6143 | |
dc.identifier.uri | ||
dc.language | eng | |
dc.publisher | Elsevier BV | |
dc.relation.ispartof | American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons | |
dc.relation.isversionof | 10.1111/ajt.16388 | |
dc.subject | Humans | |
dc.subject | Bacteremia | |
dc.subject | Cytokines | |
dc.subject | Organ Transplantation | |
dc.subject | Cohort Studies | |
dc.subject | Prospective Studies | |
dc.subject | Transplant Recipients | |
dc.title | Bacteremia in solid organ transplant recipients as compared to immunocompetent patients: Acute phase cytokines and outcomes in a prospective, matched cohort study. | |
dc.type | Journal article | |
duke.contributor.orcid | Eichenberger, Emily M|0000-0002-2469-0638 | |
duke.contributor.orcid | Ruffin, Felicia|0000-0003-2176-6462 | |
duke.contributor.orcid | Lerebours, Reginald|0000-0003-2884-3168 | |
duke.contributor.orcid | Jung, Sin-Ho|0000-0002-1473-7236 | |
duke.contributor.orcid | Macintyre, Andrew N|0000-0002-5297-0207 | |
duke.contributor.orcid | Thaden, Joshua T|0000-0002-3250-0697 | |
duke.contributor.orcid | Sinclair, Matthew|0000-0002-8003-9786 | |
duke.contributor.orcid | Palmer, Scott M|0000-0002-1370-3771 | |
duke.contributor.orcid | Alexander, Barbara D|0000-0001-5868-0529 | |
duke.contributor.orcid | Fowler, Vance G|0000-0002-8048-0897 | |
pubs.begin-page | 2113 | |
pubs.end-page | 2122 | |
pubs.issue | 6 | |
pubs.organisational-group | Duke | |
pubs.organisational-group | School of Medicine | |
pubs.organisational-group | Staff | |
pubs.organisational-group | Basic Science Departments | |
pubs.organisational-group | Clinical Science Departments | |
pubs.organisational-group | Institutes and Centers | |
pubs.organisational-group | Biostatistics & Bioinformatics | |
pubs.organisational-group | Immunology | |
pubs.organisational-group | Molecular Genetics and Microbiology | |
pubs.organisational-group | Medicine | |
pubs.organisational-group | Pathology | |
pubs.organisational-group | Medicine, Duke Human Vaccine Institute | |
pubs.organisational-group | Medicine, Infectious Diseases | |
pubs.organisational-group | Medicine, Pulmonary, Allergy, and Critical Care Medicine | |
pubs.organisational-group | Duke Cancer Institute | |
pubs.organisational-group | Duke Clinical Research Institute | |
pubs.organisational-group | Institutes and Provost's Academic Units | |
pubs.organisational-group | Initiatives | |
pubs.organisational-group | Population Health Sciences | |
pubs.organisational-group | Duke Innovation & Entrepreneurship | |
pubs.publication-status | Published | |
pubs.volume | 21 |
Files
Original bundle
- Name:
- Eichenberger BSI in Transplant AJT 2020.pdf
- Size:
- 693.4 KB
- Format:
- Adobe Portable Document Format